title: [Meningococcemia following chemotherapy for bronchial cancer].
authors.forename: Amélie
authors.initials: A
authors.lastname: Guihot
authors.forename: Inad
authors.initials: I
authors.lastname: Abi-Nasr
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Rivaud
authors.forename: Pierre
authors.initials: P
authors.lastname: Cahen
authors.forename: Geneviève
authors.initials: G
authors.lastname: Le Bourdelles
authors.forename: Louis-Jean
authors.initials: LJ
authors.lastname: Couderc
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D016190:Carboplatin / Q000008:administration & dosage; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008585:Meningitis, Meningococcal / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D009345:Neisseria meningitidis / Q000302:isolation & purification / Q000472:pathogenicity*; D014747:Vinblastine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000077235:Vinorelbine
chemical_list: D000900:Anti-Bacterial Agents; D014747:Vinblastine; D016190:Carboplatin; D000077235:Vinorelbine